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Novel molecular transport medium 
used in combination with Xpert 
MTB/RIF ultra provides rapid 
detection of Mycobacterium bovis 
in African buffaloes
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Mycobacterium bovis is the causative agent of bovine tuberculosis (bTB) in wildlife. Confirmation of M. 
bovis infection relies on mycobacterial culture, which is time-consuming. Collection and transportation 
of infectious material also pose a human health risk. PrimeStore Molecular Transport Medium (MTM) 
has been shown to effectively inactivate infectious organisms, making it a safe method for handling 
infectious samples. This study investigated an in-field sampling technique for rapid, safe detection of 
M. bovis in buffalo tissues. Potentially infected tissues from bTB test-positive buffaloes were swabbed 
at post-mortem examination and stored in PrimeStore MTM at ambient temperature until Xpert MTB/
RIF Ultra testing was performed. Additionally, tissue samples were frozen and transported before 
homogenisation for culture and Ultra testing. Oral swabs were collected from M. bovis-unexposed 
buffaloes as a negative control cohort. Mycobacterium tuberculosis complex (MTBC) DNA was detected 
by Ultra in 13/16 tissue swabs and 9/16 matched tissue homogenates from culture-confirmed M. bovis-
positive buffalo tissues. MTBC DNA was not detected in swabs from M. bovis-unexposed animals, 
showing the potentially high specificity of Ultra with PrimeStore swabs. PrimeStore MTM sample 
processing, in combination with the Ultra assay, has the potential to provide a safe, rapid post-
mortem screening test for M. bovis in buffaloes.
Bovine tuberculosis (bTB) is an important zoonosis caused by Mycobacterium bovis (M. bovis) and is responsible 
for severe economic losses and disruption of conservation programs when livestock and wildlife are  affected1,2. 
African buffaloes (Syncerus caffer) are important wildlife maintenance hosts of M. bovis and serve as a source 
of infection for other susceptible mammals sharing the same  habitat2. This highlights the potential disease 
risk and importance of its  control1,2. Diagnosis of M. bovis infection in African buffaloes typically relies on the 
measurement of cell-mediated immune (CMI) responses to M. bovis  antigens3. Buffalo TB tests include in vitro 
interferon-gamma (IFN-γ) release assays (IGRAs) and IFN-γ inducible protein 10 (IP-10) release assays (IPRA) 
that use a modified QuantiFERON-TB Gold Plus (QFT) In-tube antigen stimulation platform, and the in vivo 
single comparative intradermal tuberculin test (SCITT)4,5. However, confirmation of M. bovis infection usually 
requires mycobacterial culture and genetic speciation of mycobacterial isolates cultured from tissue specimens 
collected during post-mortem examination. Conventional culture methods, however, have suboptimal sensitivity 
and are time-consuming, taking up to 56 days before results are  available6. In addition, post-mortem examina-
tion of potentially M. bovis-infected buffaloes, and the collection, transport and storage of tissue specimens 
are considered a potential human health  risk7,8. Infectious pathogens, other than M. bovis, may also be present 
during sample collection and transport, such as Foot-and-Mouth Disease (FMD) virus, which may lead to 
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sample movement restrictions to laboratories due to the risk of spreading the disease. Movement restrictions 
placed on buffalo samples from locations with reportable diseases to laboratories may result in inadequate bTB 
surveillance in these  areas9.
PrimeStore Molecular Transport Medium (MTM), used in combination with PrimeStore swabs, has been 
shown to effectively inactivate infectious organisms, while stabilising the nucleic acids, through lysis of the cell 
membranes, destruction of proteins and enzymes, and inactivation of  nucleases10. PrimeStore MTM therefore 
provides a safer option for collection and transportation of samples that potentially pose a risk to human or 
animal health. In addition, this method may facilitate sample transport from areas that may be restricted due to 
the presence of reportable diseases (such as FMD), since it inactivates all pathogens.
The rapid Xpert MTB/RIF Ultra (Ultra) assay is an automated cartridge-based semi-quantitative nested 
real-time PCR assay that detects Mycobacterium tuberculosis complex (MTBC) DNA and rifampicin resistance 
in clinical  specimens11. The assay targets the multicopy sequences, IS6110 and IS1081, which greatly improves 
the detection of DNA in paucibacillary samples. IS1081 and IS6110 are exclusively found in MTBC members, 
which makes it ideal for samples collected from animals that may be infected with members of the  MTBC12,13. 
Although the Ultra is typically used for detection of MTBC DNA in human samples, it has been shown to 
accurately detect M. bovis in wildlife specimens from white rhinoceros (Ceratotherium simum) and elephants 
(Loxodonta africana)13, and several other wildlife  species14,15.
Therefore, the aim of this study was to investigate the combined use of the Ultra assay with PrimeStore MTM 
swab samples as a new screening technique for the detection of MTBC DNA in buffalo tissue specimens, which 
could provide a rapid and safer method for sample collection and transport, or in-field testing.
Results
Sixteen tissue samples collected from 13 buffaloes were confirmed to be M. bovis positive by mycobacterial 
culture and PCR-based speciation (Table 1). Each of these 16 culture-confirmed M. bovis positive tissue samples 
had a matching PrimeStore swab sample collected during post-mortem examination and stabilised in PrimeStore 
MTM, and a pre-culture tissue homogenate aliquot. Both the swab and tissue homogenate were tested with the 
Ultra assay prior to mycobacterial culture. The Ultra assay detected MTBC DNA in 13 of 16 (81.3%) tissue swab 
samples, while MTBC DNA was detected directly in 9 of 16 (56.3%) tissue homogenates from culture-confirmed 
M. bovis-positive specimens. The difference between the proportion of positive Ultra assay results from tissue 
homogenates compared to tissue swabs was not significant using the McNemar’s test (p > 0.05). The agreement 
between these tests were regarded as “fair” on the kappa agreement scale, with κ = 0.259 (95% confidence interval 
(CI) − 0.2 to 0.72 and standard error (SE) of 0.23).
Additionally, Ultra assay did not detect MTBC DNA in any oral swabs collected from the 12 randomly selected 
M. bovis unexposed buffaloes from historically bTB free buffalo herds (data not shown).
Discussion
The findings from this study show that the Ultra assay combined with tissue swabs that were inactivated in 
PrimeStore MTM can accurately identify culture-confirmed M. bovis positive tissues from African buffaloes. 
The swabs taken directly from dissected tissues and later tested on the Ultra assay performed similar to the Ultra 
on tissue homogenates prepared prior to culture. Recent studies have shown that Ultra provides accurate, rapid 
diagnosis of MTBC infection in livestock and wildlife when performed on tissue  homogenates13–15. However, the 
Table 1.  Ultra assay results from PrimeStore MTM tissue swab samples and tissue homogenates from culture-
confirmed M. bovis positive African buffaloes (n = 13). Positive results are shown in bold. Ultra—Xpert MTB/
RIF Ultra; LN—Lymph node; L/R—Left and right; MTM—molecular transport medium.
Buffalo number
Culture-confirmed M. bovis positive 
tissue samples
Ultra result for PrimeStore MTM 
tissue swabs Ultra result for tissue homogenates
A107 Left retropharyngeal LN MTB trace detected MTB detected low
A113 Tonsils MTB trace detected MTB not detected
A20 Tonsils MTB detected very low MTB not detected
A98 Retropharyngeal LN MTB trace detected MTB trace detected
A98 Tonsils MTB not detected MTB not detected
B15 Lung lesion MTB detected low MTB detected very low
B19 Retropharyngeal LN MTB trace detected MTB detected very low
B30 Lung lesion MTB not detected MTB not detected
B30 Mediastinal LN MTB trace detected MTB not detected
B48 Right retropharyngeal LN lesion MTB detected very low MTB detected low
B64 Abdominal serosa MTB detected very low MTB detected low
B65 L/R tracheobronchial LN MTB detected very low MTB detected very low
B8 L/R tracheobronchial LN MTB detected very low MTB detected low
C22 Scalpel MTB not detected MTB detected low
C28 Retropharyngeal LN MTB trace detected MTB not detected
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combined use of PrimeStore MTM and tissue swabs with the Ultra assay have the added advantage of providing 
more rapid test results, since it can directly be used in the Ultra assay without the extra steps of tissue process-
ing; results may even be acquired in-field if portable Ultra equipment is available (such as Cepheid’s GeneXpert 
Edge system), providing same day results. Typically, tissue samples are kept frozen at − 20 °C and transported 
to a biosafety level 3 (BSL-3) facility before being homogenised to perform the Ultra test. PrimeStore MTM 
incubated swabs do not require refrigeration and since PrimeStore MTM inactivates pathogens, samples could 
even be transported through standard postal services without biosafety concerns. Furthermore, a BSL-3 facility 
is not required for sample processing of swabs in PrimeStore MTM and samples can be handled safely without 
the risk of infection to other animals and humans.
There was a greater number of positive Ultra results using swabs than tissue homogenates. However, the dif-
ference was not significant and there was only fair agreement between the two methods. There could be various 
reasons for the discordant Ultra results between tissue swabs and matching tissue homogenate samples. Prime-
Store MTM has been shown to inactivate nucleases in samples. Since the tissue homogenate samples were not 
incubated in stabilising media (PrimeStore MTM), there may have been degradation of DNA in some samples 
during freeze–thaw cycles, which could result in a negative Ultra result, especially if the samples were paucibacil-
lary. Tissue swabs, however, did not undergo a freeze–thaw cycle prior to testing with Ultra. Also, since Ultra 
results are influenced by bacillary  load16, swab samples from tissues with visible lesions are more targeted than 
taking an aliquot of the tissue homogenate for Ultra testing, which may result in some dilution of mycobacteria 
in a larger homogenate volume than the swabs.
Studies performed with human specimens have shown that Ultra results provide a measure of the bacil-
lary load in a specimen, with a positive correlation between the semi-quantitative Ultra results and detection 
of acid-fast bacilli with smear-microscopy17. The “MTB trace detected” and “MTB not detected” Ultra results 
have been shown to be correlated with no acid-fast bacilli detected, whereas Ultra results “MTB detected high” 
and “medium” typically correlate with positive smear-microscopy  results17. The Ultra test results in this study 
included “MTB detected low”, “MTB detected very low”, “MTB trace detected” and “MTB not detected”. Since 
the “MTB trace detected” Ultra results from tissue swabs and homogenates were seen in culture-confirmed 
M. bovis positive specimens, it may indicate greater sensitivity of this method compared to smear microscopy. 
However, varying copy numbers of IS6110 and IS1081 between MTBC members and between strains have also 
been shown to influence the sensitivity and may not entirely relate to the performance of the Ultra  assay11,13. 
The bacillary load in samples in which no MTBC DNA were detected (“MTB not detected”) was likely below the 
threshold for detection by the Ultra assay, although the homogenates from the same tissue sample had a positive 
M. bovis result by mycobacterial culture and PCR speciation. This could be due to a low but viable bacillary load 
that would have increased to a detectable level during the 56 days of mycobacterial culture, which could further 
explain the discordant results between mycobacterial culture (all M. bovis positive) and Ultra results from tissue 
homogenates. Difference in sample volume between mycobacterial culture and Ultra from tissue swabs may also 
contribute to discordant results between these two methods.
The oral swabs from the M. bovis-unexposed buffaloes were all negative on the Ultra assay. These results are 
consistent with the reported high specificity of the Ultra  assay11. Interestingly, although these swabs were used 
as negative controls, the swabs would have had a greater likelihood of contamination than those collected post-
mortem, since these animals were sampled in a dusty, natural environment, where they were likely exposed to 
various environmental organisms.
The study had several limitations. Firstly, there was a small sample size of culture-confirmed M. bovis-positive 
buffaloes and oral swab samples available from the M. bovis-unexposed buffaloes, which did not allow for direct 
comparison of the same sample type tested in the Ultra. Secondly, since the Ultra assay was only performed in 
the laboratory, we were unable to compare laboratory and in-field testing with the Ultra assay and PrimeStore 
sampling platform. Finally, since tissue samples for Ultra were specifically selected based on visible lesions, it is 
unknown how the Ultra would perform using M. bovis culture-positive tissue samples with no visible lesions 
and therefore presumed low bacillary load. Future studies should include a larger sample size with buffaloes at 
various stages of infection. The application of field testing should also be investigated, which would allow more 
rapid sample processing and the use of fresh samples. Additionally, pooling swab samples from each buffalo 
should be investigated as a method to decrease the number of samples tested.
The Ultra assay with samples stored in PrimeStore MTM shows promise as a rapid post-mortem screening 
test, which could be used to identify MTBC DNA in tissue samples and ultimately identify infected herds more 
rapidly than mycobacterial culture. This test can also be used to decrease the number of samples sent for myco-
bacterial culture by identifying those that contain mycobacterial DNA. In addition, the use of PrimeStore MTM 
to safely store and transport infectious samples will safeguard human and animal health as well as permit greater 
use of samples that may otherwise be restricted from being transported to diagnostic laboratories.
Materials and methods
Animals and post-mortem sample collection. The Hluhluwe-iMfolozi Park (HiP) in KwaZulu-Natal, 
South Africa, is a game park that is endemic for M. bovis-infection in the wildlife population. During the 
2019 annual test-and-slaughter bTB control program, African buffaloes were captured, immobilised, sampled 
and tested for bTB, using the testing regime previously  described18. Bovine TB test-positive buffaloes (n = 22) 
underwent post-mortem examination as previously  described18. Various tissues with gross pathological lesions 
consistent with  bTB18 were dissected and swabbed during post-mortem examination using PrimeStore swabs 
(Longhorn Vaccines and Diagnostics, San Antonio, Texas, USA) and stored in PrimeStore MTM (Longhorn 
Vaccines and Diagnostics) at ambient temperature (which may reach temperatures up to 25 °C during winter in 
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nodes, abdominal serosa, and tracheobronchial lymph nodes. In addition, the scalpel blade used to cut tissues 
for a particular animal was also sampled on some occasions (Fig. 1). Samples with visible lesions were stored in 
separate containers and frozen at − 20 °C until processed for mycobacterial culture. Since tissue samples were not 
available from M. bovis-unexposed buffaloes, oropharyngeal swabs were collected from 12 randomly selected 
buffaloes that were tested for bTB in historically bTB-negative private game parks, as previously  described18. 
PrimeStore swab samples were stored in PrimeStore MTM at ambient temperature until further processing. All 
samples were transported to Stellenbosch University for further analyses.
Ethical approval for this study was granted by Stellenbosch University Animal Care and Use Committee 
(ACU-2019-9081). Permission to perform animal research in terms of section 20 of the Animal Diseases Act 
was granted by the South African Department of Agriculture, Land Reform and Rural Development (DALRRD), 
formerly the Department of Agriculture, Forestry and Fisheries (DAFF), South Africa (12/11/1/7/2). All buf-
faloes were handled by the Ezemvelo KZN Wildlife services’ veterinarians and game capture teams according 
to their guidelines. ARRIVE guidelines for reporting animal research have been followed as much as possible 
(https:// arriv eguid elines. org/).
Mycobacterial culture. All previously frozen tissue samples collected during post-mortem examination 
were homogenised in phosphate buffer (Becton Dickinson, Franklin Lakes, NJ, USA) with 4.8 mm stainless steel 
beads using a Bullet Blender 50 (Next Advance, Averill Park, NY, USA) for 15 min at maximum speed in a BSL-3 
laboratory at Stellenbosch University, as previously  described3. A 1 ml aliquot of the liquid fraction of each tis-
sue homogenate was used for quantitative polymerase chain reaction (qPCR) analysis by the Xpert MTB/RIF 
Ultra (Ultra) assay (Cepheid Inc., Sunnyvale, California, United States). Tissue homogenates were then further 
processed for mycobacterial culture using the standard mycobacterial culture protocol with the BBL MycoPrep 
specimen decontamination kit (Becton Dickinson) and BACTEC MGIT 960 Mycobacterial Detection System 
(Becton Dickinson), as previously  described3. Speciation by region of difference PCR was performed on all cul-
ture positive samples to confirm the presence of M. bovis19 (Fig. 1).
Xpert MTB/RIF ultra assay. The Ultra assay (Cepheid) was performed using the oropharyngeal swabs 
collected from M. bovis-unexposed buffaloes and tissue swab samples from HiP buffaloes, according to the Ultra 
alternative sample assay instructions, as previously  described13. Briefly, Xpert MTB/RIF sample lysis reagent 
(Cepheid) was mixed in a 1:1 ratio with each PrimeStore MTM stabilised swab sample and incubated for 10 min 
at room temperature (RT). Hereafter it was vortexed for 10 s before incubation at RT for 5 min followed by a 
5 s vortex step. Approximately 2 ml of the prepared sample was dispensed into the sample chamber of the Ultra 

































Scientific Reports |         (2021) 11:7061  | https://doi.org/10.1038/s41598-021-86682-5
www.nature.com/scientificreports/
tested with the Ultra assay, with sample preparation as described above. The Ultra assay classifies MTBC DNA 
detection as high, medium, low, very low or trace, based on the quantity of MTBC DNA that was detected, and 
all of these classifications were considered positive in this study. When the Ultra could not detect MTBC DNA 
(“MTB not detected”), it was considered a negative result. Rifampicin resistance was also reported but is irrel-
evant in the context of this study (Fig. 1).
Statistical analysis. Agreement between tests was calculated as Cohen’s kappa coefficient (κ) using the cal-
culator on the GraphPad Prism Software (https:// www. graph pad. com/ quick calcs/ kappa2/). The McNemar’s test 
was used to compare Ultra results from tissue swabs and tissue homogenates using the GraphPad QuickCalcs 
software https:// www. graph pad. com/ quick calcs/ McNem ar1. cfm). A p value < 0.05 was considered statistically 
significant.
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